Carcinoma suprarrenal con extensión a vena cava inferior y aurícula derecha: Reporte de caso

Else T, Kim AC, Sabolch A, Raymond V, Kandathil A, Caoili E et al. Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282-326. https://doi.org/:10.1210/er.2013-1029

Fulawka L, Patrzalek D, Halon A. Adrenal cortical carcinoma with extension into the inferior vena cava--case report and literature review. Diagn Pathol. 2014;9(1):51. https://doi.org/:10.1186/1746-1596-9-51

Cornejo KM, Afari HA, Sadow PM. Adrenocortical Carcinoma Arising in an Adrenal Rest: a Case Report and Review of the Literature. Endocr Pathol. 2017;28(2):165-170. https://doi.org/:10.1007/s12022-017-9472-9

Annamaria P, Silvia P, Bernardo C, Alessandro DL , Antonino M, Antonio B et al. Adrenocortical carcinoma with inferior vena cava, left renal vein and right atrium tumor thrombus extension. Int J Surg Case Rep. 2015;15:137-139. https://doi.org/:10.1016/j.ijscr.2015.07.008

Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg H, Beuschlein F et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma. Cancer. 2009;115(2):243-250. https://doi.org/:10.1002/cncr.24030

Aparna C, Renuka I, Bala S, Annapurna P. Adrenocortical carcinoma: Report of two cases. Indian J Endocrinol Metab. 2011;15(3):217. https://doi.org/:10.4103/2230-8210.83412

Kim KH, Park JC, Lim SY, Sohn IS, Yun KH, Cho SH et al. A Case of Non-Functioning Huge Adrenocortical Carcinoma Extending Into Inferior Vena Cava and Right Atrium. J Korean Med Sci. 2006;21(3):572. https://doi.org/:10.3346/jkms.2006.21.3.572

Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R et al. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol. 2000;165(2):223-229.http://www.ncbi.nlm.nih.gov/pubmed/10810286

Fassnacht M, Libé R, Kroiss M, Allolio B. Adrenocortical carcinoma: A clinician’s update. Nat Rev Endocrinol. 2011;7(6):323-335. https://doi.org/:10.1038/nrendo.2010.235

Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol. 2003;169(1):5-11. https://doi.org/:10.1097/01.ju.0000030148.59051.35

Raju S, Hollis K, Neglen P. Obstructive lesions of the inferior vena cava: Clinical features and endovenous treatment. J Vasc Surg. 2006;44(4):820-827. https://doi.org/:10.1016/j.jvs.2006.05.054

Young WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356(6):601-610. https://doi.org/:10.1056/NEJMcp065470

Jorda M, Madeiros B, Nadji M. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas. Appl Immunohistochem Mol Morphol AIMM. 2002;10(1):67-70. http://www.ncbi.nlm.nih.gov/pubmed/11893039

Williams AA, Higgins JPT, Zhao H, Ljunberg B, Brooks JD. CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. BMC Clin Pathol. 2009;9:9. https://doi.org/:10.1186/1472-6890-9-9

Ortiz-Rey JA, Gómez De María C, Peláez Boismorand E, Fernández Costas A, Barbosa Barreiro MJ, Antón Badiola I. [Expression of CD10 and renal cell carcinoma marker in clear cell renal cell carcinoma: analysis on tissue arrays]. Actas Urol Esp. 2006;30(3):281-286. http://www.ncbi.nlm.nih.gov/pubmed/16749584

Laan D V., Thiels CA, Glasgow A, Wise K , Thompson GB , Richards M et al. Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery. 2017;161(1):240-248. https://doi.org/:10.1016/j.surg.2016.07.040

Albero R, Sanz A, Trincado P, Monreal M. Tratamiento terapéutico del carcinoma de la corteza suprarrenal. Endocrinol y Nutr. 2006;53(7):458-466. https://doi.org/:10.1016/S1575-0922(06)71132-9

Jasim S, Habra MA. Management of Adrenocortical Carcinoma. Curr Oncol Rep. 2019;21(3). https://doi.org/:10.1007/s11912-019-0773-7

Livhits M, Li N, Yeh MW, Harari A. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease. Surgery. 2014;156(6):1531-1540; discussion 1540-1. https://doi.org/:10.1016/j.surg.2014.08.047

Wang S, Gao W-C, Chen S-S, Bai L , Luo L , Zheng X-G et al. Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database. Onco Targets Ther. 2017;10:5311-5315. https://doi.org/:10.2147/OTT.S147352

Laganà M, Grisanti S, Cosentini D, Ferrari V , Lazzari B , Ambrosin R et al. Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience. Cancers (Basel). 2020;12(4). https://doi.org/:10.3390/cancers12040941

Gaujoux S, Mihai R, joint working group of ESES and ENSAT. European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg. 2017;104(4):358-376. https://doi.org/:10.1002/bjs.10414

Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton P et al. Adjuvant Mitotane Treatment for Adrenocortical Carcinoma. N Engl J Med. 2007;356(23):2372-2380. https://doi.org/:10.1056/NEJMoa063360

Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A al. Combination Chemotherapy in Advanced Adrenocortical Carcinoma. N Engl J Med. 2012;366(23):2189-2197. https://doi.org/:10.1056/NEJMoa1200966

Puglisi S, Calabrese A, Basile V, Pia A , Reimondo G , Perotti P et al. New perspectives for mitotane treatment of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2020;34(3):101415. https://doi.org/:10.1016/j.beem.2020.101415

Ciancio G, Soloway MS. Renal cell carcinoma with tumor thrombus extending above diaphragm: Avoiding cardiopulmonary bypass. Urology. 2005;66(2):266-270. https://doi.org/:10.1016/j.urology.2005.03.039